Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Bristol/Myers Squibb Co
Recent news which mentions Bristol/Myers Squibb Co
< Previous
1
2
3
Next >
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
Today 7:01 EDT
Tags
Business
Biotechnology
Earnings
From
CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
April 22, 2025
Tags
Healthy Returns
Pfizer Inc
Health care industry
From
CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
April 09, 2025
Tags
Companies
Regeneron Pharmaceuticals Inc
Politics
From
CNBC.com News
Jim Cramer says investors should follow the post-dot-com-bubble playbook
April 03, 2025
Tags
Investing
Bristol/Myers Squibb Co
AT&T Inc
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Johnson & Johnson
Breaking News: Markets
Biotech and Pharmaceuticals
From
CNBC.com News
Cramer's Lightning Round: Deere is a buy
February 19, 2025
Tags
Investing
S&P 500
Bristol/Myers Squibb Co
From
CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
February 10, 2025
Tags
Health care industry
Pfizer Inc
Merck & Co Inc
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 06, 2025
Tags
Amazon/com Inc
Business News
Yum! Brands Inc
From
CNBC.com News
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
February 06, 2025
Tags
Companies
Health care industry
Pfizer Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
February 03, 2025
Tags
Economy
Walt Disney Co
Technology
From
CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
January 31, 2025
Tags
stocks
Amazon/com Inc
Stock Picks
From
CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
Tags
Teva Pharmaceutical Industries Ltd
Amgen Inc
Merck & Co Inc
From
CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags
Biotech and Pharmaceuticals
Pharmaceuticals
Business News
From
CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
January 14, 2025
Tags
Moderna Inc
GSK plc
KemPharm Inc
From
CNBC.com News
Bristol Myers Squibb CEO describes new drug for treating schizophrenia
January 13, 2025
Tags
U/S/ Markets
Investment Strategy
Mad Money
From
CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
January 08, 2025
Tags
Biotech and Pharmaceuticals
Health & Science
Bristol/Myers Squibb Co
From
CNBC.com News
Here are our top 10 things to watch in the stock market Monday
December 23, 2024
Tags
Markets
CNBC Investing Club: Newsletter
Alphabet Inc
From
CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
December 05, 2024
Tags
Healthy Returns
Health care industry
AstraZeneca PLC
From
CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
November 15, 2024
Tags
Stock markets
General Mills Inc
Business
From
CNBC.com News
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
October 31, 2024
Tags
Health & Science
Earnings
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Business News
CrowdStrike Holdings Inc
Exxon Mobil Corp
From
CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
October 25, 2024
Tags
Advanced Micro Devices Inc
Business
Stock markets
From
CNBC.com News
5 things to know before the stock market opens Friday
September 27, 2024
Tags
Meta Platforms Inc
Business News
Government and politics
From
CNBC.com News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
September 26, 2024
Tags
Bristol/Myers Squibb Co
US: News
Science
From
CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
Tags
Health & Science
Health care industry
Eli Lilly and Co
From
CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Health care industry
Breaking News: Politics
Merck & Co Inc
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Health care industry
Novartis AG
AstraZeneca PLC
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Bristol/Myers Squibb Co
Politics
Abbvie Inc
From
CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
July 26, 2024
Tags
Companies
Breaking news
Health care industry
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
AstraZeneca PLC
Novo Nordisk A/S
Novartis AG
From
CNBC.com News
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.